Sunpeaks Ventures Announces Third Quarter 2012 Results

            Sunpeaks Ventures Announces Third Quarter 2012 Results

PR Newswire

SILVER SPRING, Md., Nov. 14, 2012

SILVER SPRING, Md., Nov. 14, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc.
(OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") on
November 13, 2012 reported its financial results for the third quarter ended
September 30, 2012:

Third Quarter Financial Details and Operating Summary

  oGross sales for the third quarter were $1.78 million. Gross sales for the
    year-to-date were $3.25 million. Third quarter revenue in 2012 represents
    a 780% increase over revenue for the same quarter in 2011, and a 45%
    increase over the immediately preceding second quarter of 2012.
  oThe Company continues to grow its pharmaceutical license base and is now
    licensed in 38 states.
  oOperating losses, after adjusting for non-recurring expenses such as
    $196,880 associated with going public, and $535,980 of advertising and
    slotting fees, were approximately $530,000 year-to-date. The Company
    continues to manage its expenses as the business grows towards

About Sunpeaks

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare
Distribution Specialists, LLC ("HDS"), is a distributor of specialty drugs and
over-the-counter ("OTC") branded multivitamins to the healthcare provider
market. HDS also owns and markets Clotamin®, a specialized over-the-counter
multivitamin product designed for use by patients also on Warfarin®, a popular
blood thinner that has a long list of known adverse drug and food

For additional information, please visit

Contact: 888-264-4597 or

Safe Harbor Statement

Information in this document constitute forward-looking statements or
statements which may be deemed or construed to be forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
The words "forecast", "anticipate", "estimate", "project", "intend", "expect",
"should", "believe", and similar expressions are intended to identify
forward-looking statements. These forward-looking statements involve, and are
subject to known and unknown risks, uncertainties and other factors which
could cause Sunpeaks Ventures' actual results, performance (financial or
operating) or achievements to differ from the future results, performance
(financial or operating) or achievements expressed or implied by such
forward-looking statements. The risks, uncertainties and other factors are
more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities
and Exchange Commission. All forward-looking statements attributable to
Sunpeaks Ventures herein are expressly qualified in their entirety by the
above-mentioned cautionary statement. Sunpeaks Ventures disclaims any
obligation to update forward-looking statements contained in this estimate,
except as may be required by law.

SOURCE Sunpeaks Ventures, Inc.

Press spacebar to pause and continue. Press esc to stop.